Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes

被引:52
作者
Ammerschlaeger, M [1 ]
Beigel, J [1 ]
Klein, KU [1 ]
Mueller, SO [1 ]
机构
[1] Merck KGaA, Inst Toxicol, Mol Toxicol, D-64271 Darmstadt, Germany
关键词
PPAR alpha; HepG2; FAO; primary hepatocytes; fibrates; Wv; 14643;
D O I
10.1093/toxsci/kfh071
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Peroxisome proliferation is a well-defined pleiotropic effect that is mediated by the ligand inducible transcription factor peroxisome proliferator-activated receptor (PPAR) alpha. Because marked peroxisome proliferation occurs in rodents but not in humans, we aimed to elucidate the molecular and cellular determinants of this species-specificity in hepatocytes. Analysis of peroxisomal marker enzyme activities confirmed that peroxisome proliferators induced acyl-CoA oxidase (ACOX) and to a lesser extent catalase in rat hepatocytes, but not in human hepatoma HepG2 cells. Transient transfection assays revealed that ciprofibrate and Wy 14,643 induced rat but not human PPARalpha-mediated reporter gene activity in rat FAO and primary hepatocytes on rat but not on human PPARalpha response elements (PPREs). In contrast, in human HepG2 and primary human hepatocytes, peroxisome proliferators did not induce either human or rat PPARalphaactivity regardless of rat or human PPRE sequences. In addition, no induction of ACOX gene expression was observed in human hepatocytes independent of the expression level of human PPARalpha. Remarkably, no distinct peroxisome proliferation related responses were observed in human hepatocytes when rat PPARalpha was transfected, although human hepatocites were responsive to PPARalpha-mediated induction of carnitine palmitoyl transferase-1A and 3-hydroxy-3-methylglutaryl-CoA synthase. These results confirmed that PPARalpha and PPREs are important determinants for the species-specificity of peroxisome proliferation. Nevertheless, our results showed that human hepatocytes limit the extent of peroxisome proliferation regardless of PPARalpha expression.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 37 条
[1]  
Ausubel FA, 1998, CURRENT PROTOCOLS MO
[2]  
Bieber L L, 1981, Methods Enzymol, V71 Pt C, P351
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[5]   Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α [J].
Brandt, JM ;
Djouadi, F ;
Kelly, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :23786-23792
[6]   Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? [J].
Cattley, RC ;
DeLuca, J ;
Elcombe, C ;
Fenner-Crisp, P ;
Lake, BG ;
Marsman, DS ;
Pastoor, TA ;
Popp, JA ;
Robinson, DE ;
Schwetz, B ;
Tugwood, J ;
Wahli, W .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 27 (01) :47-60
[7]   Gels culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells [J].
Clavey, V ;
Copin, C ;
Mariotte, MC ;
Baugé, E ;
Chinetti, G ;
Fruchart, J ;
Fruchart, JC ;
Dallongeville, J ;
Staels, B .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 1999, 9 (03) :139-149
[8]   Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators [J].
Corton, JC ;
Lapinskas, PJ ;
Gonzalez, FJ .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 448 (02) :139-151
[9]  
Duclos S, 1997, EUR J CELL BIOL, V72, P314
[10]   A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity [J].
Gervois, P ;
Torra, IP ;
Chinetti, G ;
Grötzinger, T ;
Dubois, G ;
Fruchart, JC ;
Fruchart-Najib, J ;
Leitersdorf, E ;
Staels, B .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) :1535-1549